Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Scientific Reports|December 2, 2025
Determining the effect of femoral anteversion and hip alignment parameters on lower limb and knee alignment post-total hip arthroplastyShunichi Yokota, Tomohiro Shimizu, Hotaka Ishizu, et al.Scientific Reports|April 18, 2025
Evaluation of bone fragility in cognitively or physically impaired elderly care home patients using radiofrequency echographic multi-spectrometryHotaka Ishizu, Tomohiro Shimizu, Yuko Shimizu, et al.Expert Review of Endocrinology & Metabolism|July 26, 2021
Risks vs. benefits of switching therapy in patients with postmenopausal osteoporosisHotaka Ishizu, Kosuke Arita, Mohamad Alaa Terkawi, et al.Biomedicines|April 27, 2024
Osteoporosis, Osteoarthritis, and Subchondral Insufficiency Fracture: Recent InsightsShunichi Yokota, Hotaka Ishizu, Takuji Miyazaki, et al.Scientific Reports|January 21, 2024
Effect of longer femoral head on leg length, offset, and range of motion in total hip arthroplasty: a simulation studyTomohiro Shimizu, Takuji Miyazaki, Shunichi Yokota, et al.Scientific Reports|December 3, 2025
Ultrasonographic predictors of residual acetabular dysplasia in high-risk infantsYusuke Ohashi, Tomohiro Shimizu, Hotaka Ishizu, et al.Scientific Reports|May 5, 2026
Developmental dysplasia of the hip alters fracture patterns in femoral neck fracturesYoshio Nishida, Yuki Ogawa, Tomohiro Shimizu, et al.Journal of Bone and Mineral Metabolism|April 10, 2023
Secondary fracture rates and risk factors 1 year after a proximal femoral fracture under FLSHotaka Ishizu, Tomohiro Shimizu, Shu Yamazaki, et al.Calcified Tissue International|April 10, 2023
Comparison of the Efficacy of Zoledronate Acid or Denosumab After Switching from Romosozumab in Japanese Postmenopausal PatientsTetsuro Oue, Tomohiro Shimizu, Tsuyoshi Asano, et al.Bone|January 6, 2026
ITAM-Syk signaling mediates the rebound phenomenon after anti-RANKL antibody discontinuationHotaka Ishizu, Tomoka Hasegawa, Tomohiro Shimizu, et al.Pageof 5